Mar 04, 2020 / 01:00PM GMT
Unidentified Analyst -
All right. Good morning. I'm [Chris] from the life science tools and diagnostics research team. With me today is Bio-Techne. From Bio-Techne, we have Jim, who is CFO. He's going to go right through a presentation, and we have a breakout session next door.
So with that, let me turn it over to Jim.
James T. Hippel - Bio-Techne Corporation - Senior VP of Finance & CFO
Great. Thank you. Great to be here. Thanks for joining me early this morning. It's our first time our company has been at the Cowen conference. So it's a pleasure to be here.
Of course, our safe harbor statement and forward-looking statements, you can go to our website and read that in detail.
To start with just an overview generally of our company. Bio-Techne is actually a 40-year-old life science tools company, historically known for its reagents portfolio, primarily proteins, antibodies and immunoassays, immunoassay kits. But over the last 6 or 7 years, we've been transforming the company from what was kind of a rather sleepy, privately run public
Bio-Techne Corp at Cowen HealthCare Conference Transcript
Mar 04, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers